Genflow Biosciences PLC (LSE:GENF, OTC:GENFF) CEO Dr. Eric Leire speaks to Thomas Warner from Proactive after the longevity-focused UK based biotech company released a company update highlighting a.
The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
Capital Ltd - UK-based mining services company, with.
In conversation with Dr Eric Leire, chief executive of Genflow Biosciences, we delve into the company s groundbreaking work in the field of longevity..
Genflow Biosciences PLC (LSE:GENF, OTC:GENFF) CEO Dr. Eric Leire speaks to Thomas Warner from Proactive about the gene therapy company s work in the field.
ERYTECH and PHERECYDES announce merger and name change to PHAXIAM Therapeutics Merger approved with large majority by the shareholders of both companiesNew governance structure implementedAmbition to create a global leader in extended phage therapies to .